Summit Therapeutics Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2025: USD 0.00

Summit Therapeutics Inc. Revenue is USD 0.00 for the Trailing 12 Months (TTM) ending March 31, 2025. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Summit Therapeutics Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 455.70 K, a -75.59% change year over year.
  • Summit Therapeutics Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 1.87 M, a 156.46% change year over year.
  • Summit Therapeutics Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 728.00 K.
Key Data
Date Revenue Revenue Gross Profit Operating Income